GHK-Cu deep dive · research transcript

GHK-Cu (copper(II)-binding tripeptide)

GHK-Cu is the copper(II) complex of the naturally occurring tripeptide glycyl-L-histidyl-L-lysine. Studied in dermal and connective-tissue research models as a reference probe of fibroblast signaling, collagen I / III expression, and extracellular-matrix remodeling, it appears in the literature as the canonical peptide-copper complex rather than a systemic agent.

Batch
…
Purity
…
Vial
…
Lab
…
Compound VialSee the molecule

Vial & molecule

Drag either viewer to rotate, scroll or use +/− to zoom. Both degrade to a static card on mobile or when the browser suppresses motion.

See the moleculeFetching the structure descriptor for this compound.

Loading the Certificate of Analysis…

Resolving batch LAB-2636 against the public lab record.

Loading Lab Insights…
Verify this vial

Batch LAB-2636 resolves against the public Certificate of Analysis.

The same lookup tool lives at /verify — paste a different batch ID below to swap the resolved record inline, or open the full verification tooling to inspect purity, identity, and lab-of-record side by side.

Sample batches

Resolving the requested batch ID…

How to read this Certificate of Analysis

Five fields, plain English.

  1. Batch ID

    The lookup key — printed on the vial label and on the public certificate. Type it into the input above to swap to BPC-157, NAD+, Semaglutide, or any other assay in this run.

  2. Third-party lab

    Apex Veritas Analytical — ISO/IEC 17025-accredited, not an in-house assay. The lab name on the certificate is the auditing point of record; the printed batch resolves against the lab report, not a marketing claim about purity.

  3. Purity %

    Reported from HPLC at 214 nm — the standard identity + purity assay for the copper-tripeptide complex. The GHK-Cu CoA also reports a separate copper-content assay read against the theoretical loading for the complex (one Cu(II) per tripeptide), so the printed percentage reflects both the dominant peptide peak area and the actual metal loading on the recovered material.

  4. Test date

    The calendar date the assay was run — distinct from the manufacturing date. A recent test date means the certificate reflects the vial as it sits on the shelf today, not a snapshot from months ago.

  5. Residual solvent

    Trace synthesis solvent carried through the purification step, reported in parts-per-million against the ICH Q3C safety threshold. A clean residual-solvent panel reads as a left-over signature of how thoroughly the crude tripeptide was purified before the Cu(II) coordination step.

How this batch was made

Three steps from synthesis to a signed certificate.

Tripeptide synthesis

Solid-phase peptide synthesis assembles the three-amino-acid sequence Gly-His-Lys on a resin support using a repeated deprotection / coupling cycle, then a final cleavage yields the crude linear tripeptide ready for copper coordination.

Cu(II) coordination

The crude tripeptide is chelated to Cu(II) under controlled pH — the copper binds through the imidazole nitrogen of histidine and the alpha-amino nitrogen of glycine, with the lysine side chain stabilizing the resulting binding pocket and locking the active conformation in place.

HPLC + ESI-MS

Reverse-phase HPLC at 214 nm is the identity + purity assay — the dominant tripeptide-copper peak reads as the visual proof that the right complex is present, and a separate copper-content assay confirms the metal loading against the theoretical value. Identity is then confirmed by electrospray ionization mass spectrometry, with the observed molecular-ion mass read against the theoretical monoisotopic mass for the GHK-Cu complex (C14H24CuN6O4).

Related compounds

Other research lineages in this catalog.

Recovery peer · NAD+

NAD+ (Nicotinamide Adenine Dinucleotide)

The oxidized hydride-carrying cofactor central to mitochondrial electron transport and sirtuin / PARP signaling — paired with GHK-Cu to contrast the connective-tissue / ECM-remodeling lineage with the redox-cofactor longevity lineage.

Read the NAD+ research hub
Connective-tissue peer · BPC-157

BPC-157 (Body Protection Compound-157)

Synthetic 15-amino-acid fragment of an endogenous body-protection sequence — researched alongside GHK-Cu in connective-tissue recovery and angiogenic growth-factor studies.

Read the BPC-157 research hub
Order this batch

Add the same batch to your cart from one place.

Pick the vial size — the price, the pack total, and the Add-to-cart stepper all live on this one card. The CTA below is the only place to order this compound on the deep-dive page.

Loading the order block…

Browse the lab directory · research catalog · subscriptions